Practical guide for disease-modifying medication management of children and adolescents with sickle cell disease.
Clinical guideline published by American Society of Hematology (ASH) on
The American Society of Hematology (ASH) is the largest global professional organization dedicated to advancing the field of hematology. Established in 1958, ASH focuses on research, education, and advocacy to improve patient care and combat blood diseases worldwide.